A
Alan Rozanski
Researcher at Mount Sinai St. Luke's and Mount Sinai Roosevelt
Publications - 274
Citations - 16363
Alan Rozanski is an academic researcher from Mount Sinai St. Luke's and Mount Sinai Roosevelt. The author has contributed to research in topics: Coronary artery disease & Medicine. The author has an hindex of 57, co-authored 237 publications receiving 15111 citations. Previous affiliations of Alan Rozanski include Saint Peter's University Hospital & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
Coronary Artery Calcium for Risk Stratification of Sudden Cardiac Death: The Coronary Artery Calcium Consortium.
Alexander C. Razavi,S. M. Iftekhar Uddin,Zeina Dardari,Daniel S. Berman,Matthew J. Budoff,Michael D. Miedema,Albert D. Osei,Olufunmilayo H. Obisesan,Khurram Nasir,Alan Rozanski,John A. Rumberger,Leslee J. Shaw,Laurence S. Sperling,Seamus P. Whelton,Martin Bødtker Mortensen,Michael J. Blaha,Omar Dzaye +16 more
TL;DR: In this article , Coronary artery calcium (CAC) is used as a marker of plaque burden to assess the association between CAC and sudden cardiac death (SCD) beyond traditional risk factors.
Journal ArticleDOI
Complementary roles of scintigraphic and angiographic techniques in assessment of the extent of coronary artery disease
Jack Gutman,Alan Rozanski,Ernest V. Garcia,Jamshid Maddahi,Alfonso Tadaomi Miyamoto,Daniel S. Berman +5 more
Journal ArticleDOI
Mortality risk among patients undergoing exercise versus pharmacologic myocardial perfusion imaging: A propensity-based comparison.
Alan Rozanski,Alan Rozanski,Heidi Gransar,Heidi Gransar,Sean W. Hayes,Sean W. Hayes,John D. Friedman,John D. Friedman,Louise E.J. Thomson,Louise E.J. Thomson,Daniel S. Berman,Daniel S. Berman +11 more
TL;DR: The findings suggest the need to study the pathophysiological drivers of increased risk in association with pharmacologic testing and to convey this risk in clinical reports.
Journal ArticleDOI
Screening for coronary artery disease in diabetic patients: A commentary
Daniel S. Berman,Daniel S. Berman,Alan Rozanski,Jamal S. Rana,Jamal S. Rana,Leslee J. Shaw,Nathan D. Wong,James K. Min +7 more
TL;DR: Diabetes is a major coronary artery disease (CAD) risk factor which is increasing in prevalence, and commonly associated with asymptomatic CAD, and secondary prevention of CAD is recommended for all adult diabetic patients.